The promise of dual targeting Akt/mTOR signaling in lethal prostate cancer

Eitemau Tebyg

• Dual targeting of the Akt/mTOR signaling pathway inhibits castration-resistant prostate cancer in a genetically engineered mouse model
  gan: Floc'h, Nicolas, et al.
  Cyhoeddwyd: (2012)
• Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model
  gan: Kinkade, Carolyn Waugh, et al.
  Cyhoeddwyd: (2008)
• Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma
  gan: Ewald, Florian, et al.
  Cyhoeddwyd: (2015)
• Dual inhibition of AKT‐mTOR and AR signaling by targeting HDAC3 in PTEN‐ or SPOP‐mutated prostate cancer
  gan: Yan, Yuqian, et al.
  Cyhoeddwyd: (2018)
• Targeting glutaminase and mTOR
  gan: Tanaka, Kazuhiro, et al.
  Cyhoeddwyd: (2015)